COVID-19 vaccines and treatments nationalism: Challenges for low-income countries and the attainment of the SDGs. Issue 3 (4th March 2021)

• Record Type: Journal Article
• Authors: Nhamo, Godwell; Chikodzi, David; Kunene, Hlengiwe Precious; Mashula, Nthivhiseni
• Is Part Of: Global public health. Volume 16:Issue 3(2021)
• Page Start: 319
• Page End: 339
• Publication Date: 2021-03-04
• Subjects: COVID-19 -- vaccines -- low-income -- SDGs -- nationalism -- COVAX; Public health -- Periodicals; 362.105
• DOI: 10.1080/17441692.2020.1860249
• Languages: English
• ISSNs: 1744-1692

Abstract

ABSTRACT: The 2030 Agenda for Sustainable Development (AfSD) has the vision to leave no one behind, particularly low-income countries. Yet COVID-19 seems to have brought up new rules and approaches. Through document and critical discourse analysis, it emerges that there has been a surge in COVID-19 vaccines and treatments nationalism. Global solidarity is threatened, with the USA, United Kingdom, European Union and Japan having secured 1.3 billion doses of potential vaccines as of August 2020. Vaccines ran out even before their approval with three candidates from Pfizer-BioNTech, Moderna and AstraZeneca having shown good Phase III results in November 2020. Rich countries have gone years ahead in advance vaccines and treatments purchases. This is a testimony that the 2030 AfSD, especially SDG 3 focusing on health will be difficult to achieve. Low-income countries are left gasping for survival as the COVID-19 pandemic relegates them further into extreme poverty and deeper inequality. The paper recommends the continued mobilisation by the World Health Organisation and other key stakeholders in supporting the GAVI vaccine alliance and the Coalition for Epidemic Preparedness Innovations (COVAX) global vaccines initiative that seeks to make two billion vaccine doses available to 92 low and middle-income countries by December 2021.